Innovation with a Purpose: Leading the Way to Advance Respiratory Care
WAYNE, Pa.--(BUSINESS WIRE)--Dec. 3, 2014--
Teleflex Incorporated (NYSE: TFX), a leading global provider of
medical devices for critical care and surgery, will be featuring medical
technology designed to improve patient outcomes and reduce healthcare
costs at the American Association for Respiratory Care (AARC) Congress
2014, Dec. 9-12 in Las Vegas.
“At Teleflex, we are dedicated to solving unmet clinical needs and
delivering positive outcomes for patients and clinicians,” said James
Ferguson, President, Respiratory Division, Teleflex. “We have united
trusted brands, products and technology to help clinicians lead the way
to advance respiratory care. We look forward to sharing the value of
choosing Teleflex as a preferred partner with the entire respiratory
therapy community.”
At the meeting, Teleflex will showcase the Hudson RCI® Neptune®
Heated Humidifier with ConchaSmart® Technology offering best-in-class
features such as low water notification and an Auto Settings mode. This
innovative humidification platform provides a simple, smart, practical
solution to meet the unique needs of patients, while helping clinicians
manage time and money.
The new ISO-Gard® Mask with ClearAir™ Technology will also be
featured at the meeting. A recent study published in the Journal of
PeriAnesthesia Nursing (JOPAN) reported occupational exposure to waste
anesthetic gases (WAG) in the post-anesthesia care unit (PACU) may be
higher than standards recommend. The study evaluated and demonstrated
that perianesthesia nurses are exposed to significantly less WAG when
patients wear the ISO-Gard® Mask with ClearAir™ Technology
from Teleflex, compared to a standard cannula or face tent.1
The Softech® Plus ETCO2 Sampling Cannula will be
showcased at the meeting. The American Society of Anesthesiologists
(ASA) has developed standards for basic anesthetic monitoring and
recommends patient monitoring of CO2 during moderate or deep
sedation. The Softech® Plus Sampling Cannula uses a divided
design to deliver oxygen from one nare and sample carbon dioxide from
the other, permitting an undiluted end tidal gas sample.
Teleflex is a corporate partner of the AARC and will be hosting a Photo
Challenge at the Teleflex booth #840, with proceeds benefiting the
American Respiratory Care Foundation (ARCF) and the International
Council for Respiratory Care, a charitable organization of the ARCF.
About Teleflex Incorporated
Teleflex is a leading global provider of specialty medical devices for a
range of procedures in critical care and surgery. Our mission is to
provide solutions that enable healthcare providers to improve outcomes
and enhance patient and provider safety. Headquartered in Wayne, PA,
Teleflex employs approximately 11,500 people worldwide and serves
healthcare providers in more than 150 countries. Additional information
about Teleflex can be obtained from the company's website at teleflex.com.
Forward-Looking Statements
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our filings
with the Securities and Exchange Commission, including our Annual Report
on Form 10-K.
Teleflex, Arrow, ClearAir, ConchaSmart, Hudson RCI, ISO-Gard, LMA,
Neptune, Rusch and Softech are trademarks or registered trademarks of
Teleflex Incorporated or its affiliates.
© 2014 Teleflex
Incorporated. All rights reserved. MC-000450
Reference:
1. McGlothlin JD, Moenning JE, Cole, SS. Evaluation and Control of Waste
Anesthetic Gases in the Postanesthesia Care Unit. Journal of
PeriAnesthesia Nursing Volume 29, Issue 4, Pages 298-312, August 2014.
This study was funded in part by a grant from Teleflex. A pre-market
version of the ISO-Gard Mask was studied. The IRB study was not an
outcome study to support an FDA submission.
Source: Teleflex Incorporated
Teleflex Incorporated
Jake Elguicze
Treasurer and Vice
President, Investor Relations
610-948-2836
jake.elguicze@teleflex.com
www.teleflex.com